Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The French National Authority for Health (HAS) published new set of decisions about add-on reimbursement for medical devices in second half of November

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of 8 medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in the second half of November.

Four decisions concerned orthopedic devices:

  • Dynamic Carbon Foot 1H04Y, prosthetic foot (II energy class) (application for registration, approved)
  • HIGHLANDER, prosthetic foot (III energy class) (renewal of registration, approved)
  • SILHOUETTE, prosthetic foot (III energy class) (renewal of registration, approved)
  • PROMENADE , prosthetic foot (III energy class) (renewal of registration, approved)

Two negative decisions were released for coronary stents:

  • ABSORB GT1,  coronary stent coated with everolimus (application for registration, rejected due to insufficient expected benefit (AS))
  • ABSORB,  coronary stent coated with everolimus (application for registration, rejected due to insufficient expected benefit (AS))

Two decisions for other devices were published:

See list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.